asset sale
The deal is part of BioReference's ongoing effort to streamline its business to achieve profitability and follows the sale last year of clinical laboratory assets to Labcorp.
In Brief This Week: T2 Biosystems, Danaher, Agilent, Lucid Diagnostics, More
News items for the week of Feb. 17, 2025.
LumiraDx Shares to be Delisted From Nasdaq
The decision by Nasdaq follows the sale of essentially all of LumiraDx's assets to Roche.
Labcorp Acquiring Enzo Biochem's Clinical Lab Business for $146M
The sale is part of a restructuring initiative that Enzo Biochem launched in 2022 to concentrate on its life science business segment.
Oncocyte Laying off 40 Percent of Staff, Selling DetermaRx Test
The company has entered into a stock purchase agreement to sell 70 percent of its stake in Razor Genomics and has eliminated its COO and CSO positions.
May 7, 2020
NantHealth Q1 Revenues Decline 10 Percent
Feb 29, 2020
NantHealth Q4 Revenues Grow 6 Percent
Dec 27, 2019
Novacyt Completes Sale of Novaprep Assets
Dec 10, 2019
Enzo Biochem Fiscal Q1 Revenues Down 5 Percent
Oct 27, 2019
Edan Dx Acquires LGC Molecular Diagnostic Platform
Jun 27, 2019
Datavant Partners With Prognos
Jul 24, 2017